Electromed Inc (ELMD)

Currency in USD
28.00
+0.39(+1.41%)
Closed·
28.000.00(0.00%)
·
ELMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
27.0728.14
52 wk Range
23.0147.40
Key Statistics
Prev. Close
27.61
Open
27.43
Day's Range
27.07-28.14
52 wk Range
23.01-47.4
Volume
118.11K
Average Volume (3m)
102.96K
1-Year Change
14.4258%
Book Value / Share
6.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
48.50
Upside
+73.21%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Electromed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 48.50
(+73.21% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Freedom Broker
Buy50.00+78.57%45.00MaintainAug 26, 2026
Lake Street
Buy47.00+67.86%36.00MaintainAug 26, 2026
B.Riley
Buy40.00+42.86%38.00MaintainMay 13, 2026
Freedom Capital Markets
Buy36.00+28.57%34.00MaintainFeb 12, 2026
Roth/MKM
Buy38.00+35.71%36.00MaintainFeb 11, 2026

Electromed Inc Earnings Call Summary for Q4/2026

  • Electromed posted Q4 EPS of $0.39, beating consensus of $0.31, but revenue of $19.4M missed estimates by $90K, marking 15th straight quarter of growth.
  • Full-year fiscal 2026 revenue rose 15.3% to $73.8M with operating margin expanding to 18.8% from 15.1%; company maintains zero debt and $20.5M cash.
  • Hospital revenue declined 29% in Q4 due to longer sales cycles, though home care segment grew 16.3% to $66.6M, representing 90.2% of total revenue.
  • Management projects double-digit revenue growth for fiscal 2027 with continued operating leverage; plans to expand sales force to 70 territories.
  • CEO Jim Cunniff announced retirement in April 2027; board has initiated succession process as company targets untapped 800K diagnosed bronchiectasis patients.
Last Updated: 2026-08-25, 05:40 p/m
Read Full Transcript

Earnings

Latest Release
Aug 25, 2026
EPS / Forecast
0.39 / 0.31
Revenue / Forecast
19.41M / 19.5M
EPS Revisions
Last 90 days

ELMD Income Statement

Compare ELMD to Peers and Sector

Metrics to compare
ELMD
Peers
Sector
Relationship
P/E Ratio
20.7x−2.0x−0.4x
PEG Ratio
0.39−0.100.00
Price/Book
4.3x5.3x2.6x
Price / LTM Sales
3.2x2.6x3.0x
Upside (Analyst Target)
73.2%35.7%48.7%
Fair Value Upside
Unlock−7.9%7.0%Unlock

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.71M20.40%48.20M
Other Institutional Investors
3.52M42.07%99.39M
Public Companies & Retail Investors
3.14M37.53%88.68M
Total
8.37M100.00%236.26M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
J.E. Simmons & Co., P.C.5.78%483,82213,663
BlackRock, Inc.5.57%465,61913,149

People Also Watch

11.10
ALMS
-2.29%
4.45
TOYO
+1.60%
82.16
FLXS
+2.23%
23.20
OOMA
-0.77%

FAQ

What Is the Electromed (ELMD) Stock Price Today?

The Electromed stock price today is 28.00 USD.

What Stock Exchange Does Electromed Trade On?

Electromed is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Electromed?

The stock symbol for Electromed is "ELMD."

What Is the Electromed Market Cap?

As of today, Electromed market cap is 230.99M USD.

What Is Electromed's Earnings Per Share (TTM)?

The Electromed EPS (TTM) is 1.30.

When Is the Next Electromed Earnings Date?

Electromed will release its next earnings report on Nov 10, 2026.

From a Technical Analysis Perspective, Is ELMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Electromed Stock Split?

Electromed has split 0 times.

How Many Employees Does Electromed Have?

Electromed has 196 employees.

What is the current trading status of Electromed (ELMD)?

As of Sep 05, 2026, Electromed (ELMD) is trading at a price of 28.00 USD, with a previous close of 27.61 USD. The stock has fluctuated within a day range of 27.07 USD to 28.14 USD, while its 52-week range spans from 23.01 USD to 47.40 USD.

What Is Electromed (ELMD) Price Target According to Analysts?

The average 12-month price target for Electromed is 48.50 USD, with a high estimate of 50 USD and a low estimate of 47 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +73.21% Upside potential.

What Is the ELMD Premarket Price?

ELMD's last pre-market stock price is 27.52 USD. The pre-market share volume is 150.00, and the stock has decreased by -0.09, or -0.33%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.